Lifecome Biochemistry Co.,Ltd. (SHE:002868)
40.12
-0.04 (-0.10%)
Apr 21, 2026, 3:04 PM CST
Lifecome Biochemistry Revenue
Lifecome Biochemistry had revenue of 128.29M CNY in the quarter ending March 31, 2026, a decrease of -9.61%. This brings the company's revenue in the last twelve months to 502.95M, down -20.28% year-over-year. In the year 2025, Lifecome Biochemistry had annual revenue of 516.58M, down -20.45%.
Revenue (ttm)
502.95M
Revenue Growth
-20.28%
P/S Ratio
12.41
Revenue / Employee
916.11K
Employees
549
Market Cap
6.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 516.58M | -132.79M | -20.45% |
| Dec 31, 2024 | 649.37M | 142.37M | 28.08% |
| Dec 31, 2023 | 507.00M | 177.15M | 53.71% |
| Jan 1, 2023 | 329.85M | -33.54M | -9.23% |
| Dec 31, 2021 | 363.39M | 55.24M | 17.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Huaheng Biotechnology | 2.86B |
| Novogene | 2.26B |
| Kexing Biopharm | 1.54B |
| Xiangxue Pharmaceutical | 1.47B |
| Shenzhen Weiguang Biological Products | 1.14B |
| Wuhan Keqian Biology Co.,Ltd | 949.74M |
| Beijing Konruns Pharmaceutical | 871.31M |
| R&G PharmaStudies | 851.01M |